Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus
- 1 July 2002
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 55 (1) , 27-40
- https://doi.org/10.1016/s0166-3542(01)00223-6
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot studyThe Lancet, 2001
- Cross-Resistance Testing of Antihepadnaviral Compounds Using Novel Recombinant Baculoviruses Which Encode Drug-Resistant Strains of Hepatitis B VirusAntimicrobial Agents and Chemotherapy, 2001
- A placebo‐controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infectionJournal of Viral Hepatitis, 1999
- Perspectives for the treatment of hepatitis B virus infectionsInternational Journal of Antimicrobial Agents, 1999
- Quantitative Detection of Hepatitis B Virus DNA in Two International Reference Plasma PreparationsJournal of Clinical Microbiology, 1999
- Evaluation of Anti-Hepatitis B Virus (HBV) Drugs Using the HBV Transgenic Mouse: Application of the Semiquantitative Polymerase Chain Reaction (PCR) for Serum HBV DNA to Monitor the Drug EfficacyBiochemical and Biophysical Research Communications, 1997
- Cytotoxic T cells and viral hepatitis.Journal of Clinical Investigation, 1997
- Hepatitis B Virus ImmunopathogenesisAnnual Review of Immunology, 1995
- Enhancement of natural killer activity and interferon induction by different acyclic nucleoside phosphonatesAntiviral Research, 1994
- Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coliNature, 1979